http://purl.org/np/RAAKC0Z4kycyc8-KR5wCHbvBSgEdSt0KKn9RnK9coWCTI#Head http://purl.org/np/RAAKC0Z4kycyc8-KR5wCHbvBSgEdSt0KKn9RnK9coWCTI http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAAKC0Z4kycyc8-KR5wCHbvBSgEdSt0KKn9RnK9coWCTI#assertion http://purl.org/np/RAAKC0Z4kycyc8-KR5wCHbvBSgEdSt0KKn9RnK9coWCTI http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAAKC0Z4kycyc8-KR5wCHbvBSgEdSt0KKn9RnK9coWCTI#provenance http://purl.org/np/RAAKC0Z4kycyc8-KR5wCHbvBSgEdSt0KKn9RnK9coWCTI http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAAKC0Z4kycyc8-KR5wCHbvBSgEdSt0KKn9RnK9coWCTI#pubinfo http://purl.org/np/RAAKC0Z4kycyc8-KR5wCHbvBSgEdSt0KKn9RnK9coWCTI http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAAKC0Z4kycyc8-KR5wCHbvBSgEdSt0KKn9RnK9coWCTI#assertion http://purl.obolibrary.org/obo/DOID_5408 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAAKC0Z4kycyc8-KR5wCHbvBSgEdSt0KKn9RnK9coWCTI#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_5408 http://purl.org/np/RAAKC0Z4kycyc8-KR5wCHbvBSgEdSt0KKn9RnK9coWCTI#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAAKC0Z4kycyc8-KR5wCHbvBSgEdSt0KKn9RnK9coWCTI#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB01077 http://purl.org/np/RAAKC0Z4kycyc8-KR5wCHbvBSgEdSt0KKn9RnK9coWCTI#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAAKC0Z4kycyc8-KR5wCHbvBSgEdSt0KKn9RnK9coWCTI#association http://www.w3.org/2000/01/rdf-schema#label etidronate disodium tablets usp are indicated for the treatment of symptomatic paget s disease of bone and in the prevention and treatment of heterotopic ossification following total hip replacement or due to spinal cord injury etidronate disodium tablets are not approved for the treatment of osteoporosis etidronate disodium tablets are indicated for the treatment of symptomatic paget s disease of bone etidronate disodium therapy usually arrests or significantly impedes the disease process as evidenced by in addition reductions in pagetically elevated cardiac output and skin temperature have been observed in some patients in many patients the disease process will be suppressed for a period of at least one year following cessation of therapy the upper limit of this period has not been determined the effects of the etidronate disodium treatment in patients with asymptomatic paget s disease have not been studied however etidronate disodium treatment of such patients may be warranted if extensive involvement threatens irreversible neurologic damage major joints or major weight bearing bones etidronate disodium tablets are indicated in the prevention and treatment of heterotopic ossification following total hip replacement or due to spinal cord injury etidronate disodium tablets reduce the incidence of clinically important heterotopic bone by about two thirds among those patients who form heterotopic bone etidronate disodium tablets retard the progression of immature lesions and reduces the severity by at least half follow up data at least 9 months post therapy suggests these benefits persist in total hip replacement patients in spinal cord injury patients http://purl.org/np/RAAKC0Z4kycyc8-KR5wCHbvBSgEdSt0KKn9RnK9coWCTI#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RAAKC0Z4kycyc8-KR5wCHbvBSgEdSt0KKn9RnK9coWCTI#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAAKC0Z4kycyc8-KR5wCHbvBSgEdSt0KKn9RnK9coWCTI#association https://w3id.org/biolink/vocab/relation https://w3id.org/um/neurodkg/SymptomaticReliefIndication https://identifiers.org/drugbank:DB01077 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAAKC0Z4kycyc8-KR5wCHbvBSgEdSt0KKn9RnK9coWCTI#provenance http://purl.org/np/RAAKC0Z4kycyc8-KR5wCHbvBSgEdSt0KKn9RnK9coWCTI#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAAKC0Z4kycyc8-KR5wCHbvBSgEdSt0KKn9RnK9coWCTI#pubinfo http://purl.org/np/RAAKC0Z4kycyc8-KR5wCHbvBSgEdSt0KKn9RnK9coWCTI#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAAKC0Z4kycyc8-KR5wCHbvBSgEdSt0KKn9RnK9coWCTI#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RAAKC0Z4kycyc8-KR5wCHbvBSgEdSt0KKn9RnK9coWCTI#sig http://purl.org/nanopub/x/hasSignature FYyLE+nuyGcwqac8BWpkcQy1iENzql6mcS8/efGHsJNwmonirIibroRSYj5ecpNLcAtEiMyvd62qobW8L48H1O4brtHB10QiaDFLWzwWf1wFL/wwgT6i4Zy0CYOkJqEiFcoNP12WqSu5E3TXGdVNC/HXQMHY49+BH69DSBiQ1Xg= http://purl.org/np/RAAKC0Z4kycyc8-KR5wCHbvBSgEdSt0KKn9RnK9coWCTI#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAAKC0Z4kycyc8-KR5wCHbvBSgEdSt0KKn9RnK9coWCTI http://purl.org/np/RAAKC0Z4kycyc8-KR5wCHbvBSgEdSt0KKn9RnK9coWCTI http://purl.org/dc/terms/created 2021-06-13T12:30:04.305+02:00 http://purl.org/np/RAAKC0Z4kycyc8-KR5wCHbvBSgEdSt0KKn9RnK9coWCTI http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAAKC0Z4kycyc8-KR5wCHbvBSgEdSt0KKn9RnK9coWCTI https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAAKC0Z4kycyc8-KR5wCHbvBSgEdSt0KKn9RnK9coWCTI https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAAKC0Z4kycyc8-KR5wCHbvBSgEdSt0KKn9RnK9coWCTI https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs